Back
Ligand Pharmaceuticals Stock Predictions

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
47
LGND
Ligand Pharmaceuticals
Last Price:
$102.43
Seasonality Move:
2.02%
7 Day Trial
ALL ACCESS PASS
$
7

Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Ligand Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Ligand Pharmaceuticals has on average historically risen by 16.2% based on the past 30 years of stock performance.
-
Ligand Pharmaceuticals has risen higher in 15 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Ligand Pharmaceuticals Stock Undervalued?The current Ligand Pharmaceuticals [LGND] share price is $102.45. The Score for LGND is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Ligand Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Ligand Pharmaceuticals has on average historically risen by 16.2% based on the past 30 years of stock performance.
Ligand Pharmaceuticals Stock Rating
Sell
47
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals overpriced?
-
Ligand Pharmaceuticals has risen higher in 15 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Ligand Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ligand.com
52-Week Data
52-Week High:
129.90
52-Week Low:
77.43
Prediction Charts
Market Cap:
2B
Price in USD:
102.45
Volume:
84.6K
Beta:
1.45
Technical Analysis
SMA50:
106.00
SMA100:
110.10
SMA200:
109.38
52-Wk Change:
17.76%
Stock Predictions
-
Is Ligand Pharmaceuticals stock public?Yes, Ligand Pharmaceuticals is a publicly traded company.
-
What is the Ligand Pharmaceuticals stock quote today?The Ligand Pharmaceuticals stock price is 102.45 USD today.
-
How to buy Ligand Pharmaceuticals stock online?You can buy Ligand Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-2 | 110.85 | 109.39 | 111.42 | 108.50 |
May-5 | 109.20 | 106.35 | 109.20 | 104.99 |
May-6 | 105.25 | 103.32 | 106.81 | 102.50 |
May-7 | 104.90 | 105.62 | 106.32 | 103.36 |
May-8 | 106.92 | 102.51 | 107.37 | 99.24 |
May-9 | 102.08 | 104.48 | 107.15 | 102.08 |
May-12 | 107.54 | 106.38 | 109.20 | 104.65 |
May-13 | 106.38 | 105.63 | 107.81 | 104.55 |
May-14 | 107.51 | 105.09 | 108.45 | 104.50 |
May-15 | 104.68 | 103.04 | 105.40 | 102.69 |
May-16 | 103.00 | 104.54 | 105.19 | 103.00 |
May-19 | 104.00 | 105.31 | 105.42 | 101.84 |
May-20 | 105.36 | 104.92 | 105.36 | 102.78 |
May-21 | 103.75 | 102.45 | 104.58 | 101.40 |
Ligand Pharmaceuticals Earnings
Ligand Pharmaceuticals Earnings Report: Per Share Ligand Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ligand Pharmaceuticals Forecast Revenue Growth
Ligand Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Ligand Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.87 per share.
* Ligand Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.